STAR-LIFE: a Post-market Registry on MINIject

This study, called STAR-LIFE, is designed to gather more information about a small device known as MINIject. This tiny implant is used to help people who have a common eye condition called open-angle glaucoma. Glaucoma can damage the nerve that connects your eye to your brain, and if left untreated, it can lead to vision loss. The MINIject is already approved for use, but this study is a way for doctors and researchers to keep track of how it performs in many different patients in their regular clinics, not just in strict research settings.

The main goals of this study are to understand three key things. Firstly, how easy and practical the MINIject device is for doctors to use. Secondly, and perhaps most importantly for patients, it will collect feedback directly from people who have received the implant about how they are doing and what their vision is like. This is called 'patient-reported outcomes'. Finally, the study will carefully monitor the safety of the device over a two-year period after the surgery. By collecting all this information, we can build a better picture of how well MINIject works for people in their daily lives.

This kind of study is important because it helps ensure that treatments like MINIject continue to be good and safe options for patients over the long term. It collects 'real-world data', which means information from a wide range of patients receiving the treatment as part of their standard care. This adds to what we already know from earlier research and helps improve understanding for future patients.